An attractive sedan with an MG badge? Who’d have thought? Wheels revisits the past while looking to the future with an early ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate TEV-‘408 TEV- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback